To include your compound in the COVID-19 Resource Center, submit it here.
Kymera Therapeutics LLC (Cambridge, Mass.) raised $30 million in a series A round led by co-founder investor Atlas Venture. New investors Lilly Ventures and Amgen Ventures participated in the
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury